In the case of HSP vaccines against GBM, HSP–peptide complexes are isolated and purified from resected GBM, and are subsequently reinfused into the patient in order to induce an immune response against those tumor antigens [158]. The gene discussed is HSP90B2P; the disease is neoplasm.